Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
PLUS THERAPEUTICS, INC.
| Metric | PLUS THERAPEUTICS, INC. PSTVOther |
|---|---|
| Quality Score | 30 / 100 |
| Revenue (latest) | $5M |
| Net income (latest) | −$22M |
| Operating margin | −293.5% |
| Net margin | −429.4% |
| Return on equity | −560.2% |
| Return on assets | −137.1% |
| Return on capital (ROCE) | −381.4% |
| Debt / equity | 3.09× |
| Revenue growth (YoY) | −10.5% |
| Altman Z″ (distress) | -107.82 |
| Accruals / assets | −9.9% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.